Newsroom: Confluent Announces Significant Investment in ATI Nitinol Melt Expansion

Tech Note: Confluent Medical Technologies Receives 91% Employee Engagement Rating Amidst Extraordinary Growth

Confluent Medical Technologies, a global leader in medical device contract manufacturing, recently received a 91 percent employee engagement rating, a key indicator of organizational success reflecting exceptionally high levels of employee satisfaction with their jobs, productivity, and motivation to perform well.

“We are very proud of our employee engagement score, which reflects our commitment to our employees and our belief that they are an integral part of our success,” said Confluent Medical’s CEO and President Dean Schauer.

The industry-leading employee satisfaction rating reflects Confluent’s commitment to its core values — Customer Focus, Accountability, Teamwork, Integrity, and Innovation, Mr. Schauer added. “We take our Company Values seriously, and we work with our employees and serve our customers based on those values.”

Confluent Medical is undergoing a period of rapid growth and substantial change. In the past 18 months it has acquired and successfully integrated four companies, resulting in a 250 percent increase in revenues. As a result of this robust expansion, Confluent now offers capabilities in a wide range of products, including Nitinol components, balloon expandable stents and catheters, guidewires, implantable textiles, delivery systems, and access kits.

“We are excited about our growing family of colleagues and customers,” Schauer remarked. “Our mission is to be the medical device industry’s most trusted partner, and to achieve that goal we are dedicated to integrity, exceptional quality, and operational excellence.”

With manufacturing facilities in Fremont, California, Sunnyvale, California, Laguna Niguel, California, Warwick, Rhode Island, and San Jose, Costa Rica,
Confluent Medical has a proven track record of partnering with the medical device community to deliver world-class medical devices through innovative materials science, engineering, and manufacturing.

The company was formed in August 2015 with the acquisition of Interface Catheter Solutions by Nitinol Devices and Components. In August 2016, Confluent Medical acquired ETE Medical and its operating subsidiaries, Modified Polymer Components and Biomedical Structures. On January 3, the company formally changed the name of its component businesses to Confluent Medical Technologies, Inc.

Schauer said he was looking forward to a bright future for the combined company, with its expanded portfolio of products and services. “We are moving forward to build on the strong reputations of our component businesses and create a unified and more responsive company,” he said.

Partnering with you every step of the way

Contact Confluent Medical today and make sure your project is supported by our unmatched resources, technical expertise and proven service to meet any design, modification or manufacturing requirements.